Inderal was been run through various tests and clinical procedures to check the measurement level of a single dosage of this drug so that it can safely be recommended to all aged patients and also to check the proper chemical composition. Advanced tests were then done to test the possible reaction of this drug with other chemical substances and the drugs interaction on other medicines. The Federal Drugs Association also put propranolol through a test to check the percentage of addictive substance in each of the doses so that it could not be misused or abused by potential or regular drug addicts. The most important test that the Federal Drug Association put propranolol - Inderal through was to check its effects on the brain and nervous system coupled with alertness of an individual after usage. After all the test results were found to be satisfactory the drug was given the FDA approval for release open in the market in 1998. After this approval was given the drug was placed for sale in the market of the US.

The production of this drug is done by world renowned Manufacturers who have their roots in India. Inderal being an addictive substance based drug is however not purchasable over the counter and its purchase is strictly restricted to the presentation of a registered prescription only. The clinical description of propranolol is that it should be reduced to low quantities and sold in the market on trials to ensure that the drug has a stable future. The FDA is continuously checking and monitoring progress / declines in usage of medications which have been in the market for along time. This is why many drugs have been removed or taken out from inside the pharmaceutical markets and have been restricted to altered compositions.